Today: 16 June 2026
Browse Category

NASDAQ:ACXP 8 October 2025

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

Acurx Pharmaceuticals shares have fallen about 90% from their 52-week high, trading near $4.30 after a 1-for-20 reverse split in August. The stock briefly rallied in late September after the European Medicines Agency issued a positive opinion on its pediatric plan for ibezapolstat. Acurx remains pre-revenue with $6.1 million in cash at Q2’s end and faces additional funding needs for Phase 3 trials.
8 October 2025
·

Stock Market Today

  • Asia Markets Edge Higher Ahead of BOJ Rate Decision Amid Iran-U.S. Peace Deal Optimism
    June 16, 2026, 12:11 AM EDT. Asian stocks edged up Tuesday following gains from Iran-U.S. peace deal news. Investors shifted focus to multiple central bank decisions, highlighting an anticipated rate hike by the Bank of Japan (BOJ). The BOJ move is closely watched for its impact on global financial markets. Market participants remain cautious, balancing optimism from diplomatic progress with potential monetary tightening.

Latest articles

Nasdaq steady in late trading as oil eases, Fed up next

Nasdaq steady in late trading as oil eases, Fed up next

16 June 2026
U.S. stocks soared Monday as falling oil prices and a preliminary U.S.-Iran deal fueled a relief rally, with the Nasdaq up 3.07%, S&P 500 up 1.65%, and Dow closing at a record high; after-hours futures dipped slightly as investors awaited Wednesday’s pivotal Federal Reserve decision and Chair Kevin Warsh’s first post-meeting press conference.
Intel stock gains after BofA upgrade, foundry business in focus

Intel Gains as Chip Shares Recover

16 June 2026
Intel surged to $127.86, topping analyst targets, as chip stocks rallied on easing inflation and AI optimism, but the stock’s gains outpace consensus expectations and recent earnings remain negative; investors now await the unconfirmed July 23 earnings report for proof that demand is driving real revenue growth.
Dave & Buster’s falls after Q1 comes up short, comps slip

Dave & Buster’s falls after Q1 comes up short, comps slip

16 June 2026
Dave & Buster’s shares plunged 4.72% to $12.32, then dropped another 11.2% after hours, after Q1 revenue, adjusted profit, and comparable-store sales all missed expectations; management’s guidance for positive sales trends and free-cash-flow remains the next key catalyst as investors weigh the company’s turnaround credibility.
Go toTop